With a robust background in private equity, the fund manager has successfully executed over 30 deals, primarily targeting technology and healthcare sectors across North America and Europe. Their strategic, operator-first approach has led to notable exits, including a significant acquisition in the biotech space. Leveraging data-driven insights, they focus on growth-stage investments, enhancing value through operational improvements and market positioning. This diverse expertise underpins a proven track record in delivering substantial returns.